Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Role Summary:
The Senior Director, Senior Corporate Counsel, provides a wide range of corporate support for the organization, with particular focus on securities, corporate governance, corporate transactions, and general corporate matters. The person in this role will be able to manage multiple priorities and work in an environment with multiple stakeholders. In this role, you will provide strategic legal advice and guidance to support Dyne Therapeutics' business operations and corporate initiatives, working both independently and collaborating with others within the legal team as well as cross-functionally.
This role is based in Waltham, MA without the possibility of being remote.
Primary Responsibilities Include:
- Providing advice and counsel on company’s compliance with applicable securities laws and NASDAQ rules and regulations, including all periodic SEC 1934 Act filings
- Drafting and/or reviewing (in collaboration with cross-functional team, auditors and outside counsel, as appropriate) SEC filings, including 10-K, 10-Qs, Proxy Statement, 8-Ks, Section 16 reporting (Forms 3, 4 and 5), and ensuring compliance with SEC and NASDAQ rules and regulations
- Supporting the company’s corporate governance and corporate secretary matters relating to the company’s Board of Directors and related committees, including Sarbanes Oxley compliance.
- Assisting on executive and equity compensation matters
- Supporting company’s trading preclearance process and collaborate with finance on stock ownership and retention requirement compliance
- Collaborating cross-functionally to advise on disclosure matters, including earnings and other press releases, presentations, posters, manuscripts, significant internal communications and other announcements
- Providing support for corporate transactions, including securities offerings, financings, investments, licensing, acquisitions and divestitures and other strategic transactions by conducting due diligence, drafting and negotiating agreements, and providing legal advice on deal structures
- Providing, as needed, legal support relating to business development, compliance, corporate ethics, employment law, and GDPR matters
- Advise on legal and regulatory risks associated with product development, marketing, and commercialization activities, and develop strategies to mitigate those risks
- Monitor changes in laws and regulations that may impact Dyne Therapeutics' business operations and develop policies and procedures to ensure compliance.
- Manage relationships with external legal counsel and other advisors to support the company's legal needs
Education and Skills Requirements:
- JD from accredited law school and license to practice in at least one US jurisdiction
- 8+ years’ experience in securities and corporate governance matters in the biotech or pharmaceutical industry
- Experience advising on securities regulation, including securities law reporting, compliance and disclosure issues, shareholder meeting matters, stock exchange listing requirements, corporate governance, board matters, and executive and equity compensation
- Experience with leading corporate transactions
- Experience with privacy laws, such as GDPR
- A dedicated, interactive, proactive, and practical individual with the ability to counsel clients at all levels of the company with clear and concise advice
- A proven multi-tasker in a fast-paced environment
- Excellent communication, writing and computer skills
- Strong knowledge of corporate governance, securities regulations, and intellectual property law.
- Experience advising on corporate transactions, including mergers and acquisitions, licensing agreements, and strategic partnerships.
- Excellent negotiation and problem-solving skills.
- Ability to work independently and collaboratively in a fast-paced, dynamic environment
- Ability to collaborate well with internal and external stakeholders
- Excellent analytical, organizational and information-seeking skills; detail oriented
- Exceptional business judgment, with the ability to think strategically and give practical advice while balancing business needs with legal risks
#LI-Onsite
The statements contained herein reflect general details as necessary to describe the principles functions for this job, the level of knowledge and skill typically required, and the scope of responsibility, but should not be considered an all-inclusive listing of work requirements. Individuals may perform other duties as assigned, including work in other functional areas to cover absences or relief, to equalize peak work periods or otherwise balance workload.
This description is not intended to be constructed as an exhaustive list of duties, responsibilities, or requirements for the position. This position may change or assume additional duties at any time. The employee may be requested to perform different or additional duties as assigned. All Employees are expected to adhere to all company policies and act as a role model for company values.
Dyne Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
Similar Jobs
What We Do
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue seen with other approaches. Dyne has a broad portfolio of programs for serious muscle diseases, including candidates for myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com.
